Nachrichten zur Viatris Aktie

Viatris Recognised as a Top Employer 2023 in the UK

HATFIELD, ENGLAND / ACCESSWIRE / February 2, 2023 / Viatris, a global healthcare company, today announced that it was recognised…

Voices of Viatris: For Nathan Wilson, Family Is a Change Worth Fighting For

NORTHAMPTON, MA / ACCESSWIRE / January 31, 2023 / Viatris: When Nathan Wilson was just 19, he was violently attacked…

Could This New Drug Launch Be a Hit for Viatris?

Viatris and Kindeva Drug Delivery could soon launch a generic version of AstraZenecas Symbicort....…

Viatris closes Oyster Point, Famy acquisitions to establish eye care division

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division

Division Combines Oyster Point Pharmas Eye Care Expertise with Famy Life Sciences Phase III-ready Pipeline and Lays Foundation for Viatris…

Form 8-K Viatris Inc For: Dec 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Viatris Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference

PITTSBURGH, Dec. 23, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate…

Calliditas To Work With Viatris To Bring Nefecon To Japanese Patients

CANONSBURG (dpa-AFX) - Calliditas Therapeutics AB (CALT) has entered into a license agreement with Viatris, through its Global Healthcare Gateway,…

Shield Therapeutics To Work With Viatris To Bring Accrufer In The U.S.

CANONSBURG (dpa-AFX) - Shield Therapeutics plc (STX.L) has entered into an exclusive, multi-year agreement with Viatris Inc. (VTRS) to co-commercialize…

Calliditas Therapeutics announces license agreement with Viatris to register and commercialize specialty therapy for IgA nephropathy in Japan

Calliditas announces that it has entered into an agreement with Viatris to bring Nefecon®, a specialty therapy focused on downregulating…

Calliditas Therapeutics announces license agreement with Viatris to register and commercialize specialty therapy for IgA nephropathy in Japan

Calliditas announces that it has entered into an agreement with Viatris to bring Nefecon[®], a specialty therapy focused on downregulating…

Form 8-K Viatris Inc For: Dec 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Viatris (VTRS) Down 1.5% Since Last Earnings Report: Can It Rebound?

Viatris (VTRS) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Viatris pulls antimicrobial cream in U.S. as confirmatory trial is not feasible

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Thinking about buying stock in Lululemon Athletica, Digital Brands, COMSovereign, Viatris, or Exxon Mobil?

NEW YORK, Nov. 28, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LULU, DBGI, COMS, VTRS, and XOM. To…

Better Dividend Stock: AbbVie or Viatris?

These pharmaceutical companies are profitable and offer above-average dividends....…

Insiderhandel: President, Greater China verkauft Aktien von Viatris im Wert von 140.220$

Ni, Xiangyang (Sean) - Vorstand - Tag der Transaktion: 2022-11-25...…

XFRA : DIVIDEND/INTEREST INFORMATION - 22.11.2022 - US92556V1061

Das Instrument VIA US92556V1061 VIATRIS INC. O.N. EQUITY wird ex Dividende/Zinsen gehandelt am 22.11.2022 The instrument VIA US92556V1061 VIATRIS INC.…

XETR : DIVIDEND/INTEREST INFORMATION - 22.11.2022 - US92556V1061

Das Instrument VIA US92556V1061 VIATRIS INC. O.N. EQUITY wird ex Dividende/Zinsen gehandelt am 22.11.2022 The instrument VIA US92556V1061 VIATRIS INC.…

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Oyster Point Pharma, Inc. Buyout

Wilmington, Delaware--(Newsfile Corp. - November 21, 2022) - Rigrodsky Law, P.A. is investigating Oyster Point Pharma, Inc. ("Oyster") (NASDAQ: OYST)…

Viatris Named U.S. In-House Legal Team of the Year for Intellectual Property Litigation by LMG Life Sciences

PITTSBURGH, Nov. 18, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been…

Thinking about buying stock in Carnival Corp, Viatris, Micron Technology, Tencent Music Entertainment, or Bilibili?

NEW YORK, Nov. 16, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CCL, VTRS, MU, TME, and BILI. To…

Corporate News: PAION AG

PAION AG schließt Partnerschaft mit Viatris und baut Vertrieb in Europa aus...…

Viatris Executive Charged With Insider Trading

Prosecutors and regulators say Ramkumar Rayapureddy, global chief information officer, tipped a friend about a regulatory drug approval....…

Viatris wins court decision on AstraZeneca Symbicort patent

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zacks Earnings Trends Highlights: Disney, Take-Two, DuPont and Viatris

Disney, Take-Two, DuPont and Viatris have been highlighted in this Earnings Trends article....…

Ocuphire adds 24% as Viatris agrees to sell lead asset

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Viatris Shares Up 14% on Plans to Buy Oyster Point Pharma, Famy Life Sciences

Viatris Shares Up 14% on Plans to Buy Oyster Point Pharma, Famy Life Sciences...…

Stocks making the biggest moves midday: Carvana, Meta, Palantir, Viatris, Walgreens and more

These are the stocks posting the largest moves midday....…

Why Viatris Stock Is Jumping Today

Investors are applauding a key step in Viatris plans to return to growth....…

Viatris (VTRS) Q3 Earnings Beat, Revenues Miss Estimates

Viatris (VTRS) beats on Q3 earnings but misses sales estimates as fluctuations in foreign exchange rates continue to impact results.…

Viatris declares $0.12 dividend

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Viatris Shares Are Soaring Higher

Viatris Inc (NASDAQ: VTRS) shares are trading higher by 16.80% to $11.33 Monday morning after the company announced it will…

Shareholder Alert: Ademi LLP investigates whether Oyster Point Pharma, Inc. has obtained a Fair Price in its transaction with Viatris

MILWAUKEE, Nov. 7, 2022 /PRNewswire/ -- Ademi LLP is investigating Oyster Point Pharma (NASDAQ: OYST) for possible breaches of fiduciary…

Viatris (VTRS) Q3 Earnings Beat Estimates

Viatris (VTRS) delivered earnings and revenue surprises of 4.88% and 1.48%, respectively, for the quarter ended September 2022. Do the…

Form 8-K Viatris Inc For: Nov 07

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Viatris To Acquire Oyster Point And Famy Life Sciences To Create Ophthalmology Franchise

CANONSBURG (dpa-AFX) - Healthcare company Viatris Inc. (VTRS) announced Monday that it intends to create an ophthalmology franchise by acquiring…

Viatris to Buy Oyster Point Pharma in Ophthalmology Push >VTRS OYST

Viatris to Buy Oyster Point Pharma in Ophthalmology Push >VTRS OYST...…

Viatris Inc. Profit Climbs In Q3

CANONSBURG (dpa-AFX) - Viatris Inc. (VTRS) revealed earnings for its third quarter that increased from last yearThe companys bottom line…

ROUNDUP: Viatris Reaffirms FY22 Revenue Outlook, Declares Dividend

CANONSBURG (dpa-AFX) - While reporting financial results for the third quarter on Monday, healthcare company Viatris Inc. (VTRS) reaffirmed its…

Viatris Reports Strong Third Quarter 2022 Results

Reaffirms 2022 Guidance Ranges [1] Across Total Revenues, Adjusted EBITDA and Free Cash Flow; Driven by Solid Operating Momentum Despite…

Viatris GAAP EPS of $0.29 beats by $0.10, revenue of $4.07B misses by $70M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Viatris Q3 2022 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Viatris (VTRS) Gains As Market Dips: What You Should Know

Viatris (VTRS) closed at $10.25 in the latest trading session, marking a +1.18% move from the prior day....…

How To Attend Viatris Q3 2022 Earnings Conference Call

Viatris (NASDAQ:VTRS) will host a conference call at 08:30 AM ET on November 7, 2022, to discuss Q3 2022 earnings…

Viatris (VTRS) Gains As Market Dips: What You Should Know

Viatris (VTRS) closed at $9.97 in the latest trading session, marking a +1.94% move from the prior day....…

Viatris to Report Financial Results for the Third Quarter 2022 and Provide an Update on its February 28 Investor Event on November 7, 2022

PITTSBURGH, Oct. 24, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will announce financial results for the third quarter of 2022…

dpa-AFX ProFeed